Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
about
Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition.Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.The Pleiotropic Role of L1CAM in Tumor VasculatureThe contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.New Directions in Anti-Angiogenic Therapy for Glioblastoma.Tumour-associated macrophages as treatment targets in oncology.Angiogenesis inhibitors in tackling recurrent glioblastoma.Therapeutic targeting of the angiopoietin-TIE pathway.Tumor angiogenesis revisited: Regulators and clinical implications.Tumor angiogenesis and vascular normalization: alternative therapeutic targets.Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors.Pivotal regulators of tissue homeostasis and cancer: macrophages.Normalizing Tumoral Vessels to Treat Cancer: An Out-of-the-Box Strategy Involving TIE2 Pathway.Targeting Malignant Brain Tumors with Antibodies.Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies.Engineering and physical sciences in oncology: challenges and opportunities.Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model.Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis.Targeting tumour microenvironment by tyrosine kinase inhibitor.Improving immune-vascular crosstalk for cancer immunotherapy.COX‑2 inhibition in the endothelium induces glucose metabolism normalization and impairs tumor progression.Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.Macrophages: The Road Less Traveled, Changing Anticancer Therapy.Contribution of Tumor Endothelial Cells in Cancer Progression.Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.The role of tumor microenvironment in resistance to anti-angiogenic therapy.IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma.Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.Targeting Macrophages in Cancer: From Bench to Bedside.Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy.Molecular Ablation of Tumor Blood Vessels Inhibits Therapeutic Effects of Radiation and Bevacizumab.Glioblastoma Treatments: An Account of Recent Industrial DevelopmentsMonitoring of tumor vascular normalization: the key points from basic research to clinical applicationDiamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
P2860
Q33364010-3ECE0767-B146-4585-94A9-2745752C7240Q33650400-62656374-9FFA-4EC0-A8A5-90DD50EF780EQ36831642-A5832824-9B48-4EC1-B081-F00831B70E5FQ37458763-9F502B5E-038E-4C79-B4B3-759145A13FA5Q37601508-C445D89B-5DAA-409D-AE90-7205385E64A3Q37690651-80BAEEEB-6F54-44D8-93B1-583471E0CF6CQ38675589-A5BCEBB1-3476-479D-BD66-34C5D449C18CQ39022941-615EB335-E0F0-4E88-A100-BC1438B3F0E3Q39100693-F96F47CF-547A-4422-B070-04D792E9589AQ39259089-FFD32695-FC99-461C-9FCF-4E9D48420E07Q39321127-12FEC04D-5DFB-4EA7-B65F-56C93771A8A7Q39393740-F43675E3-7E55-4AC0-B264-6703123FE2FBQ39403862-ED57BE29-8A2E-46F2-AB3A-178525C53741Q40219738-691E5C70-4806-459B-AB7D-517E30B71D3EQ41317820-1A89BF1C-50ED-4CF9-A48A-353780156A15Q41710508-84C87168-55CE-463B-B0AD-BBF375DDDD24Q42267793-07D9D5EF-655F-4003-AB37-01136323A2BAQ47134647-B41D1874-837C-42E6-936D-CBF3DA048CD4Q47244877-05CC1EEA-DB33-481B-91BC-EA00B9A9C543Q48282942-DB58A5D4-B2D3-4A89-A015-2CCE8F6F7EF1Q48369496-39DBC992-BC56-4E86-AFC6-6F7AED716730Q48724706-861905ED-BA0C-4A9B-8030-8BD728FE0E25Q49884417-33196C29-EC98-4B1F-A2C3-9D61F02E5C4EQ49887906-FE3D5761-BF3F-4D41-B72D-F33077659300Q50051034-B330ED4B-2C9E-4B8D-B8C9-F53A903169E6Q50209286-452841E5-7CCD-4A82-B45E-DA68EBD12181Q50216662-DC1AD636-6918-4771-A591-3B1E277C9F5FQ52321369-39E1CDB1-BDD6-43A5-976C-98CBB7F8E18BQ52563257-6B1C3263-0F77-49FE-9AB6-09D49B897BB0Q52615294-4FCEDE74-C33E-41C2-9967-C2436B29A7E1Q52645823-B71DFEE4-B767-4DCE-B657-358A4B2482F5Q52719932-496B7234-A692-47AE-A938-6BECFA104E92Q55190117-5EE478D2-9B60-4273-9E5A-F352ED6D1E0AQ55315292-6D75065D-D34F-438D-8F93-4DE2B4FEA5F9Q55396890-041BC459-9565-4EE8-AB7E-54755770C074Q55415350-E817A46A-3715-4F59-B126-9FA8FFDF22E7Q55457297-A7B19CD7-CAA1-4C8D-8C3C-A036EC7B58E6Q57111067-4685EB2E-7360-4DD8-966C-D5B86C711D65Q57484416-2DB6255F-3E47-4D67-95A7-1A668A1BC466Q57817490-4FBF67EA-1026-4A73-A04A-62DA29D98200
P2860
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dual inhibition of Ang-2 and V ...... stoma by altering macrophages.
@en
type
label
Dual inhibition of Ang-2 and V ...... stoma by altering macrophages.
@en
prefLabel
Dual inhibition of Ang-2 and V ...... stoma by altering macrophages.
@en
P2093
P2860
P50
P356
P1476
Dual inhibition of Ang-2 and V ...... astoma by altering macrophages
@en
P2093
Alona Muzikansky
Ana Batista
Ching Ching Leow
Dai Fukumura
Dan G Duda
Jermaine Goveia
Jonas Kloepper
Keehoon Jung
Meenal Datta
P2860
P304
P356
10.1073/PNAS.1525349113
P407
P577
2016-04-04T00:00:00Z